Cycle of the vasoactive intestinal peptide and its binding site in a human adenocarcinoma cell line (HT 29)

Eur J Biochem. 1986 May 2;156(3):631-6. doi: 10.1111/j.1432-1033.1986.tb09624.x.

Abstract

The disappearance of vasoactive-intestinal-peptide (VIP) binding sites at the cell surface of a cultured target cell, originating from a human colonic adenocarcinoma (HT 29 cell line), was studied, after preexposition of the cell to the peptide, as a function of time, VIP concentration and temperature. Maximum effect (60-80% loss of binding capacity) was obtained after a 5-10 min exposure of the cells at 37 degrees C with a VIP concentration of 100 nM. The t1/2 of maximum disappearance was less than 2 min and the concentration of native VIP giving half-maximum decrease in 125I-VIP binding was 6 nM. The affinity of remaining binding sites for VIP was not affected compared to that of control cells (Kd = 0.3 nM). Disappearance of VIP binding sites was specific since, with the same conditions of preincubation, the specific binding of 125I-labeled epidermal growth factor to HT 29 cells was not modified. The phenomenon was reversible and 90% of binding capacity could be restored in less than 60 min by incubating cells in VIP-free medium. Correlatively we showed, by two independent experimental procedures, that 125I-VIP, initially bound to HT 29 cells, was maximally internalized after 10 min of incubation at 37 degrees C. All the data strongly suggest that: internalization of VIP is receptor-mediated; upon exposure to native VIP, VIP receptors are down-regulated or at least sequestered within HT 29 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / metabolism
  • Cell Line
  • Colonic Neoplasms / metabolism
  • Humans
  • Hydrogen-Ion Concentration
  • Receptors, Cell Surface / metabolism*
  • Receptors, Vasoactive Intestinal Peptide
  • Temperature
  • Time Factors
  • Vasoactive Intestinal Peptide / metabolism*

Substances

  • Receptors, Cell Surface
  • Receptors, Vasoactive Intestinal Peptide
  • Vasoactive Intestinal Peptide